Get in touch

Proven Connect aims to support the commercialisation of prostate cancer innovations through investment, expertise in academic and translational research and a deep understanding of patient needs.

Get in touch

We are particularly interested in hearing from companies an innovative / novel product in early-stage Development and strong pre-clinical or early trial data with the potential to…​

  • Improve screening (more accurate diagnosis/prognosis)
  • Provide for better disease management  
  • Improve drug development and clinical trial success
  • Deliver earlier efficacious treatments with fewer side effects
We welcome applications from academics looking to spin out and start ups and offer direct support and advice through the application process.​

We operate a rolling programme for applications with decisions taking 8-10 weeks from submission.  Typically, investment size is between £50,000 – £200,000. If your investment needs exceed this, please get in touch about joining our portfolio.

Successful applicants benefit from access to:

  • Mentorship – AZ
  • Clinical advice
  • Patient insight
  • Business model development
  • Follow on funding opportunities

(downloads – application form)

Link to get in touch